CD8A and neoplasm: In stark contrast, CD8+ T cells treated with 2-DG, to suppress glycolysis during T cell priming, retained a memory phenotype and had an augmented production of IFN-γ and TNF-α and, more importantly, were more efficient at controlling tumor development (27).